Patent · US Active

FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks

US10577616B2 · kind B2 · utility

0Cited by

26References

15Claims

0Family size

Assignees

DOW AGROSCIENCES LLC · US
Sangamo Therapeutics, Inc. · US

Inventors

Noel Cogan · Melbourne, AU
John White Forster · Whittlesea, AU
Matthew Hayden · Melbourne, AU
Tim Sawbridge · Melbourne, AU
German Spangenberg · Melbourne, AU
Steven R. Webb · Westfield, US
Manju Gupta · Carmel, US
W. Michael Ainley · Carmel, US
Matthew J. Henry · Indianapolis, US
Jeffrey C. Miller · Pleasanton, US
Dmitry Y. Guschin · Seojong-myeon, KR

Key dates

Filing date	Apr 2, 2018
Grant date	Mar 3, 2020
Priority date	—
Expiry date	May 26, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A40/146
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A method of gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a cell, to generate a break in the FAD2 gene and then ligating into the break a nucleic acid molecule associated with one or more traits of interest is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.